iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Ankit Gupta is appointed vice president of strategy and investments by Gland Pharma Limited

5 Sep 2023 , 01:36 PM

Mr. Ankit Gupta has been appointed as Vice-President (Strategy & Investments), a Senior Management Personnel of the Company, beginning September 4, 2023, according to a statement from Gland Pharma Limited. Mr. Ankit has worked in the pharmaceutical and biotechnology sectors for almost 15 years. He has worked on corporate strategy and growth efforts for a variety of firms. He is a financial expert and business leader.

He has a track record of successfully implementing both organic and inorganic growth projects, maximizing resources, controlling risks, and reinventing firms in changing market conditions. At Gland, he will lead projects for strategic expansion and tactical investment. Ankit formerly served as Strides Pharma Science Limited’s Vice President and Head of Corporate Development & Strategy.

Ankit was a member of the consulting leadership team for Christensen (now EY Transaction Advisory), a Mumbai-based capital market company, prior to joining Strides. He has worked in API and formulations for other pharmaceutical firms. Ankit holds additional credentials in corporate finance, private equity, valuations, business leadership, and strategy in addition to his Gold Medalist MBA in Finance.

For feedback and suggestions, write to us at editorial@iifl.com

Gland Pharma Ltd reports Rs. 231.94 crores consolidated profit in Q3FY23 |  EquityBulls

Related Tags

  • Ankit Gupta
  • Gland Pharma
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.